-
1تقرير
المؤلفون: Mehta, Sachin, Sekhavat, Mohammad Hossein, Cao, Qingqing, Horton, Maxwell, Jin, Yanzi, Sun, Chenfan, Mirzadeh, Iman, Najibi, Mahyar, Belenko, Dmitry, Zatloukal, Peter, Rastegari, Mohammad
مصطلحات موضوعية: Computer Science - Computation and Language, Computer Science - Artificial Intelligence, Computer Science - Machine Learning
URL الوصول: http://arxiv.org/abs/2404.14619
-
2تقرير
المؤلفون: Cho, Minsik, Vahid, Keivan A., Fu, Qichen, Adya, Saurabh, Del Mundo, Carlo C, Rastegari, Mohammad, Naik, Devang, Zatloukal, Peter
URL الوصول: http://arxiv.org/abs/2309.00964
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
المؤلفون: Scagliotti GV; University of Tovino, Department of Clinical and Biological Sciences, S. Luigi Hospital, Regione Gonzole 10, Orbassano (Torino) 10043, Italy. giorgio.scagliotti@unito.it, Smit E, Bosquee L, O'Brien M, Ardizzoni A, Zatloukal P, Eberhardt W, Smid-Geirnaerdt M, de Bruin HG, Dussenne S, Legrand C, Giaccone G
مؤلفون مشاركون: European Organisation for Research and Treatment of Cancer (EORTC) Lung Cancer Group (LCG)
المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2005 Oct; Vol. 50 (1), pp. 91-6.
نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study
بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print Cited Medium: Print ISSN: 0169-5002 (Print) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Adenocarcinoma, Bronchiolo-Alveolar/*drug therapy , Antineoplastic Agents, Phytogenic/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Lung Neoplasms/*drug therapy , Paclitaxel/*therapeutic use, Adenocarcinoma, Bronchiolo-Alveolar/pathology ; Adult ; Aged ; Antineoplastic Agents, Phytogenic/administration & dosage ; Antineoplastic Agents, Phytogenic/adverse effects ; Carcinoma, Non-Small-Cell Lung/pathology ; Disease Progression ; Female ; Humans ; Infusions, Intravenous ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Survival Analysis ; Treatment Outcome